Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease
The fatty liver disease MASH is one of the metabolic disorders that Nula Therapeutics is…
Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease
The fatty liver disease MASH is one of the metabolic disorders that Nula Therapeutics is pursuing. The startup’s small molecules are intended to restore the integrity of the nuclear envelope, a cellular membrane whose dysfunction can contribute to metabolic disease. The post Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease appeared…
The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease
Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care. The post The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease appeared first on MedCity News.
The End of Incrementalism: Why Healthcare Innovation is Finally Reshaping the Model
The difference between that last era and this one isn’t incremental. It’s categorical. Artificial intelligence isn’t optimizing the old system. It’s making the old system economically indefensible. The post The End of Incrementalism: Why Healthcare Innovation is Finally Reshaping the Model appeared first on MedCity News.
As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
The number of babies born in the United States fell again last year. According to new data from the Centers for Disease Control and Prevention, there were 3.6 million births in 2025, a 1% decline from 2024. The fertility rate dropped to 53.1 births per 1,000 women ages 15 to 44, down 23% since 2007….
New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
Millions of people who apply for Medicaid in the coming years will have to prove they’ve been working, going to school, or volunteering for at least a month before they can gain or retain health insurance through the government program. But Republican lawmakers in some states think the new rules — part of the GOP’s…
Concierge Care for All: Yes, It Really Is That Simple
By MATTHEW HOLT & CLAUDE You’ll recall that a few weeks back I gave Claude some prompts and my entire corpus of work on THCB and asked it to write a piece. It was about 70% my ideas and 50% my writing tone. I’m back trying it again. This time I gave it a lot…
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased. The post New Bill Seeks to Lower Out-of-Pocket Drug Costs appeared first on MedCity News.
Impact of Continuous Glucose Monitoring on Clinical Outcomes and Productivity Losses Among People Living With Type 2 Diabetes Not Using Insulin From an Employer’s Perspective
That is the title of a new paper out yesterday in the Journal of Diabetes Science and Technology from my FTI colleague Marie Steele-Adjognon, along with Martha E. Shepherd, Jon Harris-Shapiro, David Hines, Abraham Lee and Yeesha Poon. The abstract is below. Background: This study evaluated the impact of continuous glucose monitoring (CGM) on health…
New Comprehensive AI Risk and Supply Chain Transparency Guide for Healthcare
New guide provides healthcare entities with strategies to enhance AI governance, improve procurement processes, and establish shared responsibility models with vendors to better manage AI-related cybersecurity risks
Why Innovaccer Is Pouring $250M into Its Agentic AI Platform
Innovaccer is committing $250 million to expand its AI agent platform, which automates workflows across areas like prior authorization, revenue cycle management and population health. The move comes amid an ongoing debate over whether administrative AI tools can ultimately reduce costs for providers. The post Why Innovaccer Is Pouring $250M into Its Agentic AI Platform…
